Glibenclamide & Metformin Tablets

Introduction About Glibenclamide & Metformin Tablets

In the landscape of cancer therapy, Geftinat tablets shine as a beacon of hope for individuals grappling with non-small cell lung cancer (NSCLC). This comprehensive guide explores the uses, benefits, precautions, and more about Geftinat tablets, illuminating their role in empowering patients on their journey toward recovery.

Geftinat, also known as Gefitinib, is an oral medication classified as a tyrosine kinase inhibitor (TKI). It is designed to target and inhibit specific enzymes responsible for the growth of cancer cells, making it a valuable asset in the fight against NSCLC.

Targeting Cancerous Progression

Geftinat tablets assume a pivotal role in targeting cancerous progression by thwarting the activation of proteins that fuel the proliferation of cancer cells.

Potential Side Effects

While Geftinat tablets hold promise in battling cancer, they may be accompanied by certain side effects, including:

• Skin Rash
• Diarrhea
• Nausea

Promptly informing the medical team about any side effects ensures proper management and support.